
AnaptysBio, Inc. Hits New 52-Week High at $38.38
2025-10-30 18:32:16AnaptysBio, Inc. has achieved a new 52-week high of USD 38.38, reflecting a strong one-year performance of 52.99%. With a market capitalization of USD 621 million, the company demonstrates effective equity management despite its loss-making status and maintains a unique financial structure with a negative debt-to-equity ratio.
Read More
AnaptysBio Hits Day High with Strong 7.66% Intraday Surge
2025-10-16 18:59:21AnaptysBio, Inc. has experienced notable stock activity, achieving a significant intraday high on October 15, 2025. While the company has shown impressive short-term gains and resilience year-to-date, it faces challenges with operating losses and a weak long-term financial outlook amid a complex industry landscape.
Read More
AnaptysBio, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics
2025-10-07 19:19:04AnaptysBio, Inc. has recently revised its evaluation amid significant market volatility, with a stock price of $30.25. The company has shown notable returns over various periods, outperforming the S&P 500 in the short term, while experiencing a decline over the past year, reflecting its fluctuating market position.
Read MoreIs AnaptysBio, Inc. technically bullish or bearish?
2025-10-07 12:16:58As of 3 October 2025, the technical trend for AnaptysBio, Inc. has changed from mildly bullish to bullish. The MACD is bullish on both the weekly and monthly time frames, and daily moving averages also indicate a bullish stance. While Bollinger Bands show a mildly bullish trend on both weekly and monthly levels, the KST is mildly bearish on both time frames. The Dow Theory indicates a mildly bullish trend on a monthly basis, while the OBV is bullish monthly but shows no trend weekly. Overall, the current technical stance is bullish, supported by strong MACD and moving average indicators. However, multi-period return data is not available for comparison with the S&P 500....
Read MoreIs AnaptysBio, Inc. technically bullish or bearish?
2025-10-06 12:06:58As of 3 October 2025, the technical trend for AnaptysBio, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting a positive outlook. Additionally, Bollinger Bands are bullish on both time frames, and the daily moving averages also indicate a bullish stance. However, the KST shows a mildly bearish signal on both weekly and monthly charts, which slightly tempers the overall bullish sentiment. The Dow Theory indicates a mildly bullish position on both weekly and monthly time frames, while the OBV is bullish across both periods. Overall, the technical stance is bullish with moderate strength, despite some mixed signals from KST. Multi-period return data is not available for comparison with the S&P 500....
Read MoreIs AnaptysBio, Inc. technically bullish or bearish?
2025-10-05 11:52:00As of 3 October 2025, the technical trend for AnaptysBio, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also indicate a bullish stance across both time frames. The daily moving averages are bullish, while the KST shows a mildly bearish signal on both weekly and monthly charts. Dow Theory reflects a mildly bullish trend on both time frames. The On-Balance Volume is bullish for both weekly and monthly periods. In terms of performance, AnaptysBio has outperformed the S&P 500 over the past week and month, with returns of 31.21% and 37.33% respectively, while it has underperformed over the 1-year, 3-year, 5-year, and 10-year periods. Overall, the current technical stance is bullish, supported by strong momentum indicators....
Read More
AnaptysBio, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility
2025-09-30 15:53:10AnaptysBio, Inc. has recently seen a stock price increase, reflecting notable volatility over the past year. The company has outperformed the S&P 500 year-to-date, showcasing impressive returns. Technical indicators present mixed signals, suggesting both bullish and bearish trends in the short and long term.
Read MoreIs AnaptysBio, Inc. technically bullish or bearish?
2025-09-29 11:17:28As of 26 September 2025, the technical trend for AnaptysBio, Inc. has changed from mildly bearish to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly MACD remains mildly bearish, creating a mixed signal. The Bollinger Bands show a bullish outlook on the weekly timeframe but are mildly bearish on the monthly. Overall, the indicators suggest a mildly bullish sentiment with some caution due to the mixed signals from MACD and KST. In terms of performance, AnaptysBio has outperformed the S&P 500 over the past week and month, with returns of 13.15% and 18.14% respectively, but has underperformed over the longer term, particularly in the 1-year and 3-year periods....
Read MoreIs AnaptysBio, Inc. technically bullish or bearish?
2025-09-28 11:11:27As of 26 September 2025, the technical trend for AnaptysBio, Inc. has changed from mildly bearish to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly MACD remains mildly bearish. The Bollinger Bands show a bullish signal on the weekly timeframe but are mildly bearish on the monthly. Overall, the indicators suggest a mixed technical stance with a slight bullish tilt. In terms of returns, AnaptysBio has outperformed the S&P 500 over the past week and month, with returns of 13.15% and 18.14%, respectively, while it has lagged over the longer term, particularly in the 1-year and 3-year periods....
Read More





